| 标题 |
 专利、报告等 First-in-human first-in-class phase 1/2a study of the next generation CDK4-selective inhibitor PF-07220060 in patients (pts) with advanced solid tumors, enriched for HR+ HER2- mBC who progressed on prior CDK4/6 inhibitors and endocrine therapy |
| 备注 |
请asco会员帮忙下载poster，多谢多谢
💡 该求助存在备注，如果存在信息冲突，请以备注为准
|
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of Clinical Oncology 作者：Timothy A. Yap; Antonio Giordano; Erika P. Hamilton; Patricia LoRusso; Michelle Bowers; et al 出版日期：2023-06-04 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
invisight
Yinxb
DW
蓝天
xing_xing
aaaa
aajhajkahna
科研狗
林狗
pluto
璐璐
嘻嘻哈哈
123
七听
小迪
秦艽
乐空思
猖狂战神
学术文献互助
123
皖公网安备34019202002308
